Mukka Proteins Announces Unaudited Financial Results for Q3FY26
Mukka Proteins Limited announced unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board approved these results on February 12, 2026. The results were published in Business Standard and Vijaya Karnataka on February 14, 2026.
This is a standard regulatory filing for the publication of financial results and does not contain new material information that would significantly impact the company's stock or operations.
The announcement is a routine disclosure of financial results and newspaper publication, lacking specific financial performance indicators or forward-looking statements that would indicate a positive or negative sentiment.
Mukka Proteins Limited has announced its unaudited financial results for the quarter and nine months period ended December 31, 2025. The results were approved by the Board of Directors at a meeting held on February 12, 2026.
The company has published these results in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Advertisements detailing the unaudited financial results (Standalone and Consolidated) for the aforementioned period were published on February 14, 2026, in the Business Standard (English) and Vijaya Karnataka (Kannada) newspapers.
The full financial results, along with the Limited Review Report from the Statutory Auditors, are available on the company's website at https://mukkaproteins.com/images/financials/mukkaproteins/Outcome%20of%20Board%20Meeting%20_12-02-2026.pdf. They can also be accessed on the websites of the BSE Limited (www.bseindia.com) and the National Stock Exchange of India Limited (www.nseindia.com) by scanning the provided QR code.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.